Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat expectations, boosted by higher sales of cancer and other prescription drugs, despite multimillion-dollar legal problems from talc and opioids. Here’s what the company reported compared with Wall Street estimates, based on a survey of analysts by Refinitiv: Adjusted earnings per share: $ 2.12… Read More »
NEW YORK/LOS ANGELES (Reuters) – Johnson & Johnson Inc’s statement was unequivocal. FILE PHOTO: Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York October 15, 2015. REUTERS/Lucas Jackson “The FDA has tested Johnson’s talc since the ’70s. Every single time it did not contain asbestos,” the company said in a… Read More »
Nearly 12,000 women have sued Johnson & Johnson, with most claiming the talc in its well-known product Johnson’s Baby Powder caused their ovarian cancer. They now have a new potential legal front. In a recent case, a group of plaintiffs argued that the talc was contaminated with asbestos, a carcinogen considered unsafe at any level… Read More »